1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Antidepressant Market in the US 2015-2019

Antidepressant Market in the US 2015-2019

  • January 2015
  • -
  • Infiniti Research Limited
  • -
  • 104 pages

Summary

Table of Contents

Search Inside

About Depression
According to the WHO, depression is a common mental disorder which contributes significantly to the global burden of disease. It affects people across communities in the world. It is characterized by sadness, loss of interest or pleasure, feelings of guilt or low self-worth, disturbed sleep or appetite, feelings of tiredness, and poor concentration, as stated by the WHO. Depression can roughly be categorized into six different types. A patient with severe depression can have suicidal thoughts or behaviors. According to a 2012 WHO estimate, approximately 3,000 suicides take place each day, resulting in more than a million deaths per annum. Depression can be recurrent, and can be severely debilitating for an individual. In patients with mild depression, the patient can be treated with medications, and in moderate or severe depression, a patient needs both medication and professional psychotherapy in terms of counseling. It has been reported by the WHO in 2008, that depression equally affects men and women, but women have a 50 percent higher tendency to get affected by depression than men. According to the CDC, depression can lead to adverse behavioral traits in an individual such as, alcoholism, smoking, and sleep disturbance. According to the CDC factsheet, one out of every 10 people is affected with depression in the US. Major depressive disorder is among the most debilitating disorders in the US, and affects approximately 14.8 million adults in the country, aged 18 years and above, according to the NIMH in the US.

TechNavio's analysts forecast the Antidepressant market in the US to grow at a CAGR of [4.08] percent over the period 2014-2019.


Covered in this Report
This report covers the present scenario and the growth prospects of the Antidepressant market in the US for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of depression. The Antidepressant market in the US is segmented based on the mechanism of action of the drugs used to treat depression, as illustrated below:

• Tricyclic Antidepressants
• Serotonin Norepinephrine Reuptake Inhibitors
• Selective Serotonin Reuptake Inhibitors
• Monoamine Oxidase Inhibitors
• Others

The report also presents the vendor landscape and a corresponding detailed analysis of the top five vendors in the Antidepressant market in the US. The vendor landscape section includes a market share analysis of the major vendors along with the competitive performances of their product portfolios. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.
TechNavio's report, Antidepressant Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. It covers the landscape of the Antidepressant market in the US and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.


Key Vendors
• Actavis
• Eli Lilly and Company
• GlaxoSmithKline
• Otsuka Pharmaceutical
• Pfizer

Other Prominent Vendors
• Abbott Laboratories
• AstraZeneca
• Aurobindo Pharma
• Bristol-Myers Squibb
• Dr. Reddy's Laboratories
• H. Lundbeck
• Janssen Pharmaceuticals
• Lupin
• Novartis
• Pierre Fabre
• Shire
• Somerset Pharmaceuticals
• Sun Pharmaceutical
• Sunovion Pharmaceuticals
• Takeda Pharmaceutical
• Teva Pharmaceutical
• Torrent Pharmaceuticals
• Valeant Pharmaceuticals


Market Driver
• Rise in Patient Population
• For a full, detailed list, view our report


Market Challenge
• Threat from Patent Expiries
• For a full, detailed list, view our report


Market Trend
• Growing Public Awareness
• For a full, detailed list, view our report


Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Opportunity in Antidepressants in global market - 2017

Opportunity in Antidepressants in global market - 2017

  • $ 4500
  • Industry report
  • March 2017
  • by Feedback Business Consulting

This report provides insight into the current market scenario, structure and practices. In depth market scenario includes: - Current market size estimate - Revenues by players - Top 5 Companies - Market ...

Global Antidepressants Market - Segmented by Antidepressant Therapies, Depressive Disorders, and Geography (2017 - 2022)

Global Antidepressants Market - Segmented by Antidepressant Therapies, Depressive Disorders, and Geography (2017 - 2022)

  • $ 4250
  • Industry report
  • January 2017
  • by Mordor Intelligence LLP

The global antidepressants market is estimated to grow to approximately USD 13.4 billion by 2020, at a CAGR of 1.8%. Depression affects an estimated 121 million people worldwide and the antidepressant ...

Trazodone Sales, Price Analysis, & Sales Forecast - 2017

Trazodone Sales, Price Analysis, & Sales Forecast - 2017

  • $ 1100
  • Industry report
  • April 2017
  • by Fore Pharma

Fore Pharma has released its new research, Trazodone Sales, Price Analysis, & Sales Forecast – 2017. Find out the sales of Trazodone worldwide and by countries in North America, Europe, Japan, BRIC, ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market in the US

  • April 2017
    44 pages
  • Therapy  

    Serotonin Speci...  

    Antidepressant  

  • United States  

View report >

Stroke Statistics in the US

  • April 2017
    4 pages
  • Stroke  

    Blood Disease  

  • United States  

View report >

Infectious Disease Statistics and Anesthetics Market in Finland

  • April 2017
    11 pages
  • Infectious Dise...  

    Anesthetics  

  • Finland  

View report >

Related Market Segments :

Antidepressant
Pharmaceutical
Depression

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.